{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T21:44:32Z","timestamp":1778622272022,"version":"3.51.4"},"reference-count":40,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Int J Immunopathol Pharmacol"],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:p>Objectives: In the context of human immunodeficiency virus (HIV) treatment, the emergence of therapeutic failures with existing antiretroviral drugs presents a significant challenge. This study aims to employ advanced molecular modeling techniques to identify potential alternatives to current antiretroviral agents. Methods: The study focuses on three essential classes of antiretroviral drugs: nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), and protease inhibitors (PIs). Computational analyses were performed on a database of 3,343,652 chemical molecules to evaluate their binding affinities, pharmacokinetic properties, and interactions with viral reverse transcriptase and protease enzymes. Molecular docking, virtual screening, and 3D pharmacophore modeling were utilized to identify promising candidates. Results: Molecular docking revealed compounds with high binding energies and strong interactions at the active sites of target enzymes. Virtual screening narrowed down potential candidates with favorable pharmacological profiles. 3D pharmacophore modeling identified crucial structural features for effective binding. Overall, two molecules for class 1, 7 molecules for class 2, and 2 molecules for class 3 were selected. These compounds exhibited robust binding affinities, interactions with target enzymes, and improved pharmacokinetic properties, showing promise for more effective HIV treatments in cases of therapeutic failures. Conclusion: The combination of molecular docking, virtual screening, and 3D pharmacophore modeling yielded lead compounds that hold potential for addressing HIV therapeutic failures. Further experimental investigations are essential to validate the efficacy and safety of these compounds, with the ultimate goal of advancing toward clinical applications in HIV management.<\/jats:p>","DOI":"10.1177\/03946320231207514","type":"journal-article","created":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T06:21:27Z","timestamp":1697610087000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":3,"title":["Revolutionizing antiretroviral therapy for human immunodeficiency virus\/AIDS: A computational approach using molecular docking, virtual screening, and 3D pharmacophore building to address therapeutic failure and propose highly effective candidates"],"prefix":"10.1177","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-5097-0886","authenticated-orcid":false,"given":"Azzeddine","family":"Annan","sequence":"first","affiliation":[{"name":"Research Center of Plant and Microbial Biotechnologies, Biodiversity and Environment, Faculty of Sciences, Mohammed V University, Rabat, Morocco"},{"name":"National Reference Laboratory for HIV, Virology Department, Institute National of Hygiene, Rabat, Morocco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noureddine","family":"Raiss","sequence":"additional","affiliation":[{"name":"Research Center of Plant and Microbial Biotechnologies, Biodiversity and Environment, Faculty of Sciences, Mohammed V University, Rabat, Morocco"},{"name":"National Reference Laboratory for HIV, Virology Department, Institute National of Hygiene, Rabat, Morocco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"El Harti","family":"Elmir","sequence":"additional","affiliation":[{"name":"National Reference Laboratory for HIV, Virology Department, Institute National of Hygiene, Rabat, Morocco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdelkarim","family":"Filali-Maltouf","sequence":"additional","affiliation":[{"name":"Research Center of Plant and Microbial Biotechnologies, Biodiversity and Environment, Faculty of Sciences, Mohammed V University, Rabat, Morocco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leila","family":"Medraoui","sequence":"additional","affiliation":[{"name":"Research Center of Plant and Microbial Biotechnologies, Biodiversity and Environment, Faculty of Sciences, Mohammed V University, Rabat, Morocco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hicham","family":"Oumzil","sequence":"additional","affiliation":[{"name":"National Reference Laboratory for HIV, Virology Department, Institute National of Hygiene, Rabat, Morocco"},{"name":"Laboratory of Biotechnology, Medical and Pharmacy School, Mohammed V University, Rabat, Morocco"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2023,10,18]]},"reference":[{"key":"bibr1-03946320231207514","doi-asserted-by":"publisher","DOI":"10.1016\/j.sbi.2019.11.011"},{"key":"bibr2-03946320231207514","doi-asserted-by":"publisher","DOI":"10.1016\/bs.enz.2021.06.006"},{"key":"bibr3-03946320231207514","first-page":"95","volume":"7","author":"Lv Z","year":"2015","journal-title":"HIV\/AIDS (Auckland, N.Z.)"},{"key":"bibr4-03946320231207514","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S192735"},{"key":"bibr5-03946320231207514","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.14.2.327-335.2001"},{"key":"bibr6-03946320231207514","doi-asserted-by":"publisher","DOI":"10.1186\/s12981-020-00294-z"},{"key":"bibr7-03946320231207514","unstructured":"Treatment Failure. NIH [Internet]. [cit\u00e9 17 juill 2023]. Disponible sur: https:\/\/clinicalinfo.hiv.gov\/en\/glossary\/treatment-failure"},{"key":"bibr8-03946320231207514","unstructured":"What to do if an HIV treatment fails. Verywell health. [cit\u00e9 24 juill 2023]. Disponible sur: https:\/\/www.facebook.com\/verywell. https:\/\/www.verywellhealth.com\/what-to-do-if-an-hiv-treatment-fails-49163"},{"key":"bibr9-03946320231207514","unstructured":"Drug Resistance. NIH [Internet]. [cit\u00e9 17 juill 2023]. Disponible sur: https:\/\/hivinfo.nih.gov\/understanding-hiv\/fact-sheets\/drug-resistance"},{"key":"bibr10-03946320231207514","unstructured":"Antiretroviral treatment failure and associated factors among HIV patients on first-line antiretroviral treatment in Sekota, northeast Ethiopia. AIDS Research and Therapy. Full Text [Internet]. [cit\u00e9 17 juill 2023]. Disponible sur: https:\/\/aidsrestherapy.biomedcentral.com\/articles\/10.1186\/s12981-020-00294-z"},{"key":"bibr11-03946320231207514","unstructured":"Global HIV programme [Internet]. [cit\u00e9 17 juill 2023]. Disponible sur: https:\/\/www.who.int\/teams\/global-hiv-hepatitis-and-stis-programmes\/hiv\/treatment\/hiv-drug-resistance"},{"key":"bibr12-03946320231207514","unstructured":"Fact sheet: HIV drug resistance [Internet]. [cit\u00e9 17 juill 2023]. Disponible sur: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hiv-drug-resistance"},{"key":"bibr13-03946320231207514","unstructured":"HIV drug resistance: problems and perspectives - PMC [Internet]. [cit\u00e9 17 juill 2023]. Disponible sur: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3892620\/"},{"key":"bibr14-03946320231207514","unstructured":"HIV drug resistance - PAHO\/WHO. Pan American health organization [Internet]. [cit\u00e9 17 juill 2023]. Disponible sur: https:\/\/www.paho.org\/en\/topics\/hiv-drug-resistance"},{"key":"bibr15-03946320231207514","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2010.03.013"},{"key":"bibr16-03946320231207514","unstructured":"Pharmacophore modeling: advances, limitations, and current utility in. JRLCR [Internet]. [cit\u00e9 17 juill 2023]. Disponible sur: https:\/\/www.dovepress.com\/pharmacophore-modeling-advances-limitations-and-current-utility-in-dru-peer-reviewed-fulltext-article-JRLCR"},{"key":"bibr17-03946320231207514","unstructured":"Structure-based pharmacophore modeling, virtual screening, molecular docking, ADMET, and molecular dynamics (MD) Simulation of Potential Inhibitors of PD-L1 from the library of marine natural products - PMC [Internet]. [cit\u00e9 17 juill 2023]. Disponible sur: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC8777599\/"},{"key":"bibr18-03946320231207514","unstructured":"2,4-Dihydropyrano [2,3-c] pyrazole: discovery of new lead as through pharmacophore modelling, atom-based 3D-QSAR, virtual screening and docking strategies for improved anti-HIV-1 chemotherapy - sciencedirect [Internet]. [cit\u00e9 17 juill 2023]. Disponible sur: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1658365515000072"},{"key":"bibr19-03946320231207514","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2019.04.023"},{"key":"bibr20-03946320231207514","unstructured":"HIV-1 genotypic drug resistance interpretation\u2019s algorithms [Internet]. [cit\u00e9 9 juill 2023]. Disponible sur: https:\/\/hivfrenchresistance.org\/"},{"key":"bibr21-03946320231207514","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-7000-1_26"},{"key":"bibr22-03946320231207514","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jcim.0c00675"},{"key":"bibr23-03946320231207514","unstructured":"Chemical Computing Group (CCG). Research [Internet]. [cit\u00e9 5 f\u00e9vr 2023]. Disponible sur: https:\/\/www.chemcomp.com\/Research-Citing_MOE.htm"},{"key":"bibr24-03946320231207514","doi-asserted-by":"publisher","DOI":"10.1186\/1758-2946-3-33"},{"key":"bibr25-03946320231207514","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2018.01.010"},{"key":"bibr26-03946320231207514","unstructured":"Maestro. Schr\u00f6dinger [Internet]. [cit\u00e9 19 juill 2023]. Disponible sur: https:\/\/www.schrodinger.com\/products\/maestro"},{"key":"bibr27-03946320231207514","unstructured":"PyMOL. pymol.org [Internet]. [cit\u00e9 28 ao\u00fbt 2022]. Disponible sur: https:\/\/pymol.org\/2\/"},{"key":"bibr28-03946320231207514","unstructured":"pkCSM. Predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures [Internet]. [cit\u00e9 20 juill 2023]. Disponible sur: https:\/\/pubs.acs.org\/doi\/epdf\/10.1021\/acs.jmedchem.5b00104"},{"key":"bibr29-03946320231207514","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-4453(89)80076-3"},{"key":"bibr30-03946320231207514","unstructured":"Zidovudine - an overview. Sciencedirect topics [Internet]. [cit\u00e9 22 ao\u00fbt 2023]. Disponible sur: https:\/\/www.sciencedirect.com\/topics\/pharmacology-toxicology-and-pharmaceutical-science\/zidovudine"},{"key":"bibr31-03946320231207514","unstructured":"Effects of standard breakfast on pharmacokinetics of oral zidovudine in patients with AIDS. Antimicrobial agents and chemotherapy [Internet]. [cit\u00e9 22 ao\u00fbt 2023]. Disponible sur: https:\/\/journals.asm.org\/doi\/10.1128\/aac.37.10.2153"},{"key":"bibr32-03946320231207514","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21249470"},{"key":"bibr33-03946320231207514","doi-asserted-by":"publisher","DOI":"10.3390\/molecules181012051"},{"key":"bibr34-03946320231207514","doi-asserted-by":"publisher","DOI":"10.2174\/1568026611313090004"},{"key":"bibr35-03946320231207514","unstructured":"Frontiers. Hierarchical graph representation of pharmacophore models [Internet]. [cit\u00e9 26 juill 2023]. Disponible sur: https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2020.599059\/full"},{"key":"bibr36-03946320231207514","unstructured":"Pharmmaker pharmacophore modeling and hit identification based on druggability simulations-Lee-2020-protein. Science-Wiley online library [Internet]. [cit\u00e9 26 juill 2023]. Disponible sur: https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/pro.3732"},{"key":"bibr37-03946320231207514","doi-asserted-by":"publisher","DOI":"10.1002\/wcms.1468"},{"key":"bibr38-03946320231207514","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25204829"},{"key":"bibr39-03946320231207514","unstructured":"(1) (PDF) Pharmacophore modeling for antitargets [Internet]. [cit\u00e9 26 juill 2023]. Disponible sur: https:\/\/www.researchgate.net\/publication\/236652809_Pharmacophore_Modeling_for_Antitargets#fullTextFileContent"},{"key":"bibr40-03946320231207514","unstructured":"Importance of pharmacophore in drug design - rasa life sciences [Internet]. [cit\u00e9 26 juill 2023]. Disponible sur: https:\/\/www.rasalifesciences.com\/computational-drug-discovery-informatics\/importance-of-pharmacophore-in-drug-design\/"}],"container-title":["International Journal of Immunopathology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/03946320231207514","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/03946320231207514","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/03946320231207514","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T10:00:40Z","timestamp":1777456840000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/03946320231207514"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":40,"alternative-id":["10.1177\/03946320231207514"],"URL":"https:\/\/doi.org\/10.1177\/03946320231207514","relation":{},"ISSN":["0394-6320","2058-7384"],"issn-type":[{"value":"0394-6320","type":"print"},{"value":"2058-7384","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1]]},"article-number":"03946320231207514"}}